Search research articles
Contact Us
Filters
Showing results (141-150 of 164) with videos related to
Page
of 17
Sort By:
British Journal of Haematology
|
November 11, 2021
Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapy
Stephen Booth, Helen M Curley, Csilla Varnai, et al.
Nature Cancer
|
March 25, 2022
Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO study
Sean H Lim, Beth Stuart, Debora Joseph-Pietras, et al.
Blood Advances
|
August 14, 2025
Camidanlumab Tesirine for Relapsed or Refractory Classic Hodgkin Lymphoma: A Phase 2 Study
Alex F Herrera, Stephen M Ansell, Pier Luigi Zinzani, et al.
Vox Sanguinis
|
March 25, 2025
International Forum on the Use of Irradiated Blood in Patients With Haematological Malignancy: Responses
Xiao-Yin Zhang, Michael Murphy, Graham P Collins, et al.
Vox Sanguinis
|
March 25, 2025
International Forum on the Use of Irradiated Blood in Patients With Haematological Malignancy: Summary
Xiao-Yin Zhang, Michael Murphy, Graham P Collins, et al.
British Journal of Haematology
|
April 29, 2022
A national service for delivering CD19 CAR-Tin large B-cell lymphoma - The UK real-world experience
Andrea Kuhnl, Claire Roddie, Amy A Kirkwood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 20, 2025
Erratum: Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma
Franck Morschhauser, Gilles Salles, Laurie H Sehn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 24, 2025
Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma
Franck Morschhauser, Gilles Salles, Laurie H Sehn, et al.
Blood
|
October 13, 2023
The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma
Pietro R Di Ciaccio, Mark N Polizzotto, Kate Cwynarski, et al.
Hemasphere
|
February 26, 2026
Outcomes of second-line axicabtagene ciloleucel for large B-cell lymphoma in the UK
Andrea Kuhnl, Amy A Kirkwood, Michael Northend, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 164) with videos related to
Sort By:
Page
of 17
British Journal of Haematology
|
November 11, 2021
Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapy
Stephen Booth, Helen M Curley, Csilla Varnai, et al.
Nature Cancer
|
March 25, 2022
Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO study
Sean H Lim, Beth Stuart, Debora Joseph-Pietras, et al.
Blood Advances
|
August 14, 2025
Camidanlumab Tesirine for Relapsed or Refractory Classic Hodgkin Lymphoma: A Phase 2 Study
Alex F Herrera, Stephen M Ansell, Pier Luigi Zinzani, et al.
Vox Sanguinis
|
March 25, 2025
International Forum on the Use of Irradiated Blood in Patients With Haematological Malignancy: Responses
Xiao-Yin Zhang, Michael Murphy, Graham P Collins, et al.
Vox Sanguinis
|
March 25, 2025
International Forum on the Use of Irradiated Blood in Patients With Haematological Malignancy: Summary
Xiao-Yin Zhang, Michael Murphy, Graham P Collins, et al.
British Journal of Haematology
|
April 29, 2022
A national service for delivering CD19 CAR-Tin large B-cell lymphoma - The UK real-world experience
Andrea Kuhnl, Claire Roddie, Amy A Kirkwood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 20, 2025
Erratum: Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma
Franck Morschhauser, Gilles Salles, Laurie H Sehn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 24, 2025
Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma
Franck Morschhauser, Gilles Salles, Laurie H Sehn, et al.
Blood
|
October 13, 2023
The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma
Pietro R Di Ciaccio, Mark N Polizzotto, Kate Cwynarski, et al.
Hemasphere
|
February 26, 2026
Outcomes of second-line axicabtagene ciloleucel for large B-cell lymphoma in the UK
Andrea Kuhnl, Amy A Kirkwood, Michael Northend, et al.
Page
of 17